Bronchodilator responses to salbutamol using diskhaler versus metered-dose inhaler

Journal of Asthma

Volumn 35, Issue 6, 1998, Pages 505-511

  Kou, M ^a   Kumana, C R ^a,c   Ip, M S M ^b   Lauder, I J ^c   Lam, W K ^b   Chan, J C K ^b  

^a Division of Clinical Pharmacology   (Hong Kong)

^b Division of Respiratory Medicine   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Controlled comparison; Diskhaler; Dose response; MDI; Salbutamol

Indexed keywords

SALBUTAMOL;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; INTERMETHOD COMPARISON; METERED DOSE INHALER; PEAK EXPIRATORY FLOW;

EID: 0031703607     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909809071004     Document Type: Article

References (49)

1. Kemp JP: Approaches to asthma management. Realities and recommendations. Arch Intern Med 153:805-812 (1993).
2. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign: Guidelines for management of asthma in adults: 1. Chronic persistent asthma. Br Med J 301:651-653 (1990).
3. National Asthma Education Program. Sheffer AL (Chair, Expert Panel on Management of Asthma): Guidelines for the Diagnosis and Management of Asthma. Office of Prevention, Education, and Control; National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. US Dept of Health and Human Services, 1991.
4. British Thoracic Society Participants - Barnes PJ, Barnett AH, Brewis RAL, et al: Guidelines for the management of asthma: a summary. Br Med J 306: 776-777 (1993).
5. British Thoracic Society, The Research Unit of the Royal College of Physicians of London, the King's Fund Centre, and the National Asthma Campaign, the British Paediatric Association and the British Paediatric Respiratory Group, British Association for Accident and Emergency, the Royal College of General Practitioners and the General Practitioners in Asthma Group. Guidelines on the management of asthma. Thorax 48(Suppl):S1-S24 (1993).
6. Chapman KR, Kesten, Szalai JP: Regular vs asneeded inhaled salbutamol in asthma control. Lancet 343:1379-1382 (1994).
7. Saunders KB: Misuse of inhaled bronchodilator agents. Br Med J 1:1037-1038 (1965).
8. Orehek J, Gayrard P, Grimaud C, et al: Patient error in use of bronchodilator metered aerosols. Br Med J 1:76 (1976).
9. Paterson IC, Crompton GK: Use of pressurized aerosols by asthmatic patients. Br Med J 1:76-77 (1976).
10. Newman SP, Pavia D, Clarke SW: How should a pressurized β-adrenergic bronchodilator be inhaled? Eur J Respir Dis 62:3-20 (1981).
11. Crompton GK: Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 63(Suppl 119):101-104 (1982).
12. Newman SP: Metered dose pressurized aerosols and the ozone layer. Eur Respir J 3:495-497 (1990).
13. Newman S: Aerosol inhalers. Br Med J 300:1286-1287 (1990).
14. Pover GM, Langdon CG, Jones SR, Fidler C: Evaluation of a breath operated powder inhaler. J Int Med Res 16:201-203 (1988).
15. Delivery systems for inhaled drugs in asthma. Drug Ther Bull 27(17):66-68 (1989).
16. Brown PH, Lenney J, Armstrong S, Ning ACWS, Crompton GK: Breath-actuated inhalers in chronic asthma: comparison of diskhaler and turbohaler for delivery of beta-agonists. Eur Respir J 5:1143-1145 (1992).
17. Lundback B, Rawlinson DW, Palmer JBD: Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 48:148-153 (1993).
18. Duncan D, Paterson IC, Harris D, Crompton GK: Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional pressurized aerosol. Br J Clin Pharmacol 4:669-671 (1977).
19. Svedmyr N, Lofdahl C, Svedmyr K: The effect of powder aerosol compared to pressurized aerosol. Eur J Respir Dis 63(Suppl 119):81-88 (1982).
20. Bronsky E, Bucholtz GA, Busse WW, Chervinsky P, Condemi J, Ghafouri MA, et al: Comparison of inhaled albuterol powder and aerosol in asthma. J Allergy Clin Immunol 79:741-747 (1987).
21. Zainudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG: Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurized metered dose inhaler, as dry powder, and as a nebulised solution. Thorax 45: 469-473 (1990).
22. Kumana CR, So SY, Lauder IJ, Ip MSM, Lam WK, Kou M: An audit of anti-asthmatic drug utilization, technique and understanding. J Asthma 30:263-269 (1993).
23. Buyse M, Firket P, Nedwick M, Starr M: Data Analysis for Clinical Medicine (Chalmers TC, editor). International University Press, 1988.
24. Minitab. Data Analysis Software Release 7.2. Minitab Inc., State College, PA, 1989.
25. Zhong NS: Peak expiratory flow (PEF) in normal subjects and patients with bronchial asthma. Chung-Hua Chieh Ho Ho Hu Hs I Hsi Chi Ping Tsa Chia 8:138-141 (1985).
26. Gregg I, Nunn AJ: Peak expiratory flow in normal subjects. Br Med J 3:282-284 (1973).
27. Wright BM, McKerrow CB: Maximum forced expiratory flow rate as a measure of ventilatory capacity (with a description of a new portable instrument for measuring it). Br Med J 2:1041-1047 (1959).
28. Wright BM: A miniature Wright peak-flow meter. Br Med J 2:1627-1628 (1978).
29. Williams MH Jr: Evaluation of asthma. Editorial. Chest 76:3-4 (1979).
30. Tesculescu DB, Hannhart B, Malvestio P, Bahlaoui A, Sadoul P: Evaluation of the performance of 2 mini-flow meters. Rev Mal Respir 4:121-125 (1987).
31. Brand PLP, Waalkens HJ, Duiverman EJ, van Essen-Zandvliet EEM, the Dutch CNSLC Study Group: Inaccuracy of portable peak flow meters: correction is not needed. Acta Paediatr 86:888-889 (1997).
32. Williams MH Jr, Kane C, Shim CS: Treatment of asthma with triamcinolone delivered by aerosol. Am Rev Respir Dis 109:538-543 (1974).
33. Williams MH Jr, Kane C: Dose response of patients with asthma to inhaled isoproterenol. Am Rev Respir Dis 3:321-324 (1975).
34. Cheong B, Reynolds SR, Rajan G, Ward MJ: Intravenous β-agonist in severe acute asthma. Br Med J 297: 448-450 (1988).
35. Kumana CR, Marlin GE: Selectivity of beta adrenoceptor agonists and antagonists. In Recent Advances in Clinical Pharmacology 1 (Turner P, Shang DG, editors). Churchill Livingstone, Edinburgh, London, and New York, 1978, pp. 31-54.
36. Nowak RM, Pensler MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, Tomlanovich MC: Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 11:64-69 (1982).
37. Henry RL, Mellis CM, South RT, Simpson SJ: Comparison of peak expiratory flow rate and forced expiratory volume in one second in histamine challenge studies in children. Er J Dis Chest 76:167-170 (1982).
38. Vaughan TR, Weber RW, Tipton WR, Nelson HS: Comparison of PEFR and FEV1 in patients with varying degrees of airway obstruction. Effect of modest altitude. Chest 95:558-562 (1989).
39. Wun YT: Comparison of peak expiratory flow rates read by two portable instruments. J Hong Kong Med Assoc 46:61-65 (1994).
40. Emerman CL, Cydulka RK: Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 27:159-163 (1996).
41. Gautrin D, D'Aquino LC, Gagnon G, Malo JL, Cartier A: Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 106:1419-1426 (1994).
42. Hume KM, Gandevia B: Forced expiratory volume before and after isoprenaline. Thorax 12:276-278 (1957).
43. Pain MCF, Read J: Patterns of response to bronchodilator in young patients with asthma. Aust Ann Med 12:216-220 (1963).
44. Melchor R, Biddiscombe MF, Mak VHK, Short MD, Spiro SG: Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 48:506-511 (1993).
45. Newman SP, Weisz AWB, Talaee N, Clarke SW: Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 46:712-716 (1991).
46. Ressor Nimmo CJ, Chen DNM, Martinusen SM, Ustad TI, Ostrow DN: Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharmacother 27:922-927 (1993).
47. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Dwong T, Ball M, et al: Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1:917-922 (1989).
48. Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, et al: Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396 (1990).
49. Beasley R, Nishima S, Pearce N, Crane J. β-agonist therapy and asthma mortality in Japan. Lancet 351: 1406-1407 (1998).